Genentech Provides Update on Studies of Investigational Biooncology Agents to...
Centre Daily Times: 5 views since Thursday, May 15, 2008 at 09:32 PM
Genentech, Inc. (NYSE:DNA) today announced results from studies of several investigational agents targeting the biological cancer pathways of HER (human epidermal growth factor receptor) signaling, Hedgehog signaling and apoptosis (programmed cell death). These data will be presented during the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place May 30 to June 3 ...

Published in: Society